Cargando…
Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma
Pheochromocytomas and paragangliomas are endocrine tumors belonging to the family of neural crest cell-derived neoplasms. They have an extremely variable clinical course, characterized by a non-negligible percentage of relapse and/or metastasis after radical surgery. To date, there are no reliable m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404897/ https://www.ncbi.nlm.nih.gov/pubmed/36009360 http://dx.doi.org/10.3390/biomedicines10081813 |
_version_ | 1784773746751438848 |
---|---|
author | Bima, Chiara Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Gesmundo, Iacopo Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko |
author_facet | Bima, Chiara Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Gesmundo, Iacopo Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko |
author_sort | Bima, Chiara |
collection | PubMed |
description | Pheochromocytomas and paragangliomas are endocrine tumors belonging to the family of neural crest cell-derived neoplasms. They have an extremely variable clinical course, characterized by a non-negligible percentage of relapse and/or metastasis after radical surgery. To date, there are no reliable methods to predict the metastatic potential of these neoplasms, despite several clinical, molecular, and histopathological factors that have been extensively studied in the literature as predictors of the recurrence and/or metastasis in these neoplasms with different performances and results. In this review, we aimed to discuss and analyze the most important clinical and histopathological tools for predicting recurrence risk in patients affected by pheochromocytomas or paragangliomas. Thus, we compared the main available predictive models, exploring their applications in stratifying patients’ risks. In conclusion, we underlined the importance of simple and validated tools to better define disease aggressiveness and establish tailored patients’ treatments and follow-ups. |
format | Online Article Text |
id | pubmed-9404897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94048972022-08-26 Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma Bima, Chiara Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Gesmundo, Iacopo Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko Biomedicines Review Pheochromocytomas and paragangliomas are endocrine tumors belonging to the family of neural crest cell-derived neoplasms. They have an extremely variable clinical course, characterized by a non-negligible percentage of relapse and/or metastasis after radical surgery. To date, there are no reliable methods to predict the metastatic potential of these neoplasms, despite several clinical, molecular, and histopathological factors that have been extensively studied in the literature as predictors of the recurrence and/or metastasis in these neoplasms with different performances and results. In this review, we aimed to discuss and analyze the most important clinical and histopathological tools for predicting recurrence risk in patients affected by pheochromocytomas or paragangliomas. Thus, we compared the main available predictive models, exploring their applications in stratifying patients’ risks. In conclusion, we underlined the importance of simple and validated tools to better define disease aggressiveness and establish tailored patients’ treatments and follow-ups. MDPI 2022-07-28 /pmc/articles/PMC9404897/ /pubmed/36009360 http://dx.doi.org/10.3390/biomedicines10081813 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bima, Chiara Bioletto, Fabio Lopez, Chiara Bollati, Martina Arata, Stefano Procopio, Matteo Gesmundo, Iacopo Ghigo, Ezio Maccario, Mauro Parasiliti-Caprino, Mirko Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title | Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title_full | Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title_fullStr | Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title_full_unstemmed | Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title_short | Clinical and Pathological Tools for Predicting Recurrence and/or Metastasis in Patients with Pheochromocytoma and Paraganglioma |
title_sort | clinical and pathological tools for predicting recurrence and/or metastasis in patients with pheochromocytoma and paraganglioma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404897/ https://www.ncbi.nlm.nih.gov/pubmed/36009360 http://dx.doi.org/10.3390/biomedicines10081813 |
work_keys_str_mv | AT bimachiara clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT biolettofabio clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT lopezchiara clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT bollatimartina clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT aratastefano clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT procopiomatteo clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT gesmundoiacopo clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT ghigoezio clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT maccariomauro clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma AT parasiliticaprinomirko clinicalandpathologicaltoolsforpredictingrecurrenceandormetastasisinpatientswithpheochromocytomaandparaganglioma |